Influenza Vaccine Market Research Report by Vaccine Type (Inactivated, Live Attenuated, and Recombinant), by Age Group (Adolescent Vaccination, Adult Vaccination, and Infant Vaccination), by Administration Route, by Distribution Channel, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19
The United States Influenza Vaccine Market size was estimated at USD 1,016.78 Million in 2020 and expected to reach USD 1,106.86 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.86% from 2020 to 2026 to reach USD 1,692.35 Million by 2026.
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage: This research report categorizes the Influenza Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Vaccine Type, the Influenza Vaccine Market was studied across Inactivated, Live Attenuated, and Recombinant.
Based on Age Group, the Influenza Vaccine Market was studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination.
Based on Administration Route, the Influenza Vaccine Market was studied across Intramuscular, Intranasal, and Oral.
Based on Distribution Channel, the Influenza Vaccine Market was studied across Government Medical Office, Hospital & Clinic, Retail Pharmacy, and Urgent Care Unit.
Based on Geography, the Influenza Vaccine Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Influenza Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Influenza Vaccine Market, including Altimmune, Inc., AstraZeneca, Emergent BioSolutions Inc., F. Hoffmann-La Roche Ltd, FluGen inc., GSK Group, Medicago, Merck & Co., Inc., Moderna Inc., Novavax, Inc., Pfizer Inc., Sanofi Pasteur, and Seqirus by CSL Limited.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as: 1. What is the market size and forecast of the United States Influenza Vaccine Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the United States Influenza Vaccine Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Influenza Vaccine Market? 4. What is the competitive strategic window for opportunities in the United States Influenza Vaccine Market? 5. What are the technology trends and regulatory frameworks in the United States Influenza Vaccine Market? 6. What is the market share of the leading vendors in the United States Influenza Vaccine Market? 7. What modes and strategic moves are considered suitable for entering the United States Influenza Vaccine Market?
Our reports have been used by over 10K customers, including:
Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are...
This study ’s Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants.
184 pages •
By Global Industry Analysts
• Apr 2021
- Global Algae Fats Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Algae Fats estimated at US$875.5 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Foods & Supplements, one...
275 pages •
By Global Industry Analysts
• Apr 2021
- Global Periodontal Therapeutics Market to Reach $605.5 Million by 2027
- Amid the COVID-19 crisis, the global market for Periodontal Therapeutics estimated at US$336.9 Million in the year 2020, is projected to reach a revised size of US$605.5 Million by 2027, growing at aCAGR of 8.7% over the period 2020-2027....
163 pages •
By Global Industry Analysts
• Apr 2021
- Global Fibromyalgia Therapeutics Market to Reach $3.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Fibromyalgia Therapeutics estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 2% over the analysis period...
Retinitis Pigmentosa - Opportunity Assessment and Forecast
Retinitis pigmentosa (RP) is an inherited retinal dystrophy that is caused by mutations in genes that code for proteins involved in maintenance and function of the photoreceptor cells, cones and rods.While RP genotypes are heterogenous,...
U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), By Animal Type (Canine, Feline), And Segment Forecasts, 2021 - 2028 U.S. Veterinary Oncology Market Growth & Trends The U.S. veterinary oncology market size is expected...
“Anti-CD20 antibody – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Anti-CD20 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.